Back to Results
First PageMeta Content
Anatomy / Eric N. Olson / Phospholamban / Endocardium / Ventricular hypertrophy / Mona Nemer / Heart failure / Endocardial fibroelastosis / Cardiovascular disease / Health / Heart diseases / Cardiology


Document Date: 2007-10-05 21:41:20

Open Document

File Size: 47,62 KB

Share Result on Facebook

Company

Discussion 31 CO / /

IndustryTerm

therapy for heart failure / /

MedicalCondition

ventricular tachycardia / cardiac hypertrophy / cardiac myosin heavy chain mutation causing endocardial fibroelastosis / cardiomyopathies / Heart failure / inherited heart disease / physiological cardiac hypertrophy / /

MedicalTreatment

gene therapy / /

Organization

Novartis Foundation / /

Person

Brian DeBosch / Stefanie Dimmeler / Pieter A. Doevendans Controlling / Joppe Nijman / Leon de Windt / Seigo Izumo Role / Nadine Winn / Mitsuhiro Kamisago / Marie Jose Goumans / Timothy A. McKinsey / Michael R. Bristow / Matthew R. Taylor / Christine Seidman / Roy van der Meel / Nassim Dali-Youcef / Julie R. McMullen / Gregory Bock (Organizer) / Mona Nemer / Anne Aries / Loren J. Field / Hiroshi Akazawa / Hao Wang / Christopher Donald Emmerson / Joachim P. Schmitt / Eva J. Vlug / Jamie Goode / Nicolaas de Jonge / Jonathan G. Seidman Sarcomere / Johannes Backs / Eric N. Olson / Arnold M. Katz Closing / Dennis McNamara / Nadia Rosenthal / Lothar Rössig / /

Position

General / /

ProgrammingLanguage

Pascal / /

Technology

gene therapy / gene expression / /

SocialTag